{"id":"https://openalex.org/W3131746895","doi":"https://doi.org/10.1093/jnci/djab015","title":"Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials","display_name":"Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials","publication_year":2021,"publication_date":"2021-02-03","ids":{"openalex":"https://openalex.org/W3131746895","doi":"https://doi.org/10.1093/jnci/djab015","mag":"3131746895","pmid":"https://pubmed.ncbi.nlm.nih.gov/33616650","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8502480"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/djab015","doi":"https://doi.org/10.1093/jnci/djab015","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/djab015","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI: Journal of the National Cancer Institute","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8502480/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065153048","display_name":"Zachary William Neil Veitch","orcid":"https://orcid.org/0000-0002-3223-5045","observed_orcids":["https://orcid.org/0000-0002-3223-5045"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Zachary W Veitch","raw_affiliation_strings":["Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-3223-5045","affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036010865","display_name":"Daniel Shepshelovich","orcid":"https://orcid.org/0000-0002-9145-618X","observed_orcids":["https://orcid.org/0000-0002-9145-618X"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA","IL"],"is_corresponding":false,"raw_author_name":"Daniel Shepshelovich","raw_affiliation_strings":["Department of Internal Medicine, Sackler School of Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-9145-618X","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Sackler School of Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103722527","display_name":"Christina Gallagher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Christina Gallagher","raw_affiliation_strings":["Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028677586","display_name":"Lisa E. Wang","orcid":"https://orcid.org/0000-0001-9726-0383","observed_orcids":["https://orcid.org/0000-0001-9726-0383"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lisa Wang","raw_affiliation_strings":["Department of Biostatistics, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112795141","display_name":"Albiruni R. Abdul Razak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Albiruni R Abdul Razak","raw_affiliation_strings":["Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088186975","display_name":"Anna Spreafico","orcid":"https://orcid.org/0000-0002-3034-3042","observed_orcids":["https://orcid.org/0000-0002-3034-3042"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Anna Spreafico","raw_affiliation_strings":["Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-3034-3042","affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041145711","display_name":"Philippe Lucien Bedard","orcid":"https://orcid.org/0000-0002-6771-2999","observed_orcids":["https://orcid.org/0000-0002-6771-2999"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Philippe L Bedard","raw_affiliation_strings":["Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-6771-2999","affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000204204","display_name":"Lillian L. Siu","orcid":"https://orcid.org/0000-0002-3500-0540","observed_orcids":["https://orcid.org/0000-0002-3500-0540"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lillian L Siu","raw_affiliation_strings":["Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-3500-0540","affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037416583","display_name":"Lori M. Minasian","orcid":"https://orcid.org/0000-0002-0472-4079","observed_orcids":["https://orcid.org/0000-0002-0472-4079"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori Minasian","raw_affiliation_strings":["Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":"https://orcid.org/0000-0002-0472-4079","affiliations":[{"raw_affiliation_string":"Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022267545","display_name":"Aaron Richard Hansen","orcid":"https://orcid.org/0000-0002-2363-8707","observed_orcids":["https://orcid.org/0000-0002-2363-8707"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Aaron R Hansen","raw_affiliation_strings":["Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-2363-8707","affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5022267545"],"corresponding_institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"],"apc_list":{"value":4738,"currency":"USD","value_usd":4738},"apc_paid":null,"fwci":5.5682,"has_fulltext":false,"cited_by_count":62,"citation_normalized_percentile":{"value":0.97337203,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"113","issue":"8","first_page":"980","last_page":"988"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.4417000114917755,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.4417000114917755,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.41819998621940613,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.08349999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/underreporting-of-adverse-events","display_name":"underreporting of adverse events","score":0.8510000109672546},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.7450000047683716},{"id":"https://openalex.org/keywords/pro-ctcae","display_name":"PRO-CTCAE","score":0.9829999804496765},{"id":"https://openalex.org/keywords/ctcae","display_name":"CTCAE","score":0.8939999938011169},{"id":"https://openalex.org/keywords/physician-patient-agreement","display_name":"patient-physician agreement","score":0.8970000147819519},{"id":"https://openalex.org/keywords/adverse-event-severity","display_name":"adverse event severity","score":0.453000009059906},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.6930000185966492},{"id":"https://openalex.org/keywords/dyspnea","display_name":"dyspnea","score":0.9539999961853027},{"id":"https://openalex.org/keywords/limb-edema","display_name":"limb edema","score":0.9789999723434448},{"id":"https://openalex.org/keywords/sexual-health","display_name":"sexual health","score":0.6389999985694885},{"id":"https://openalex.org/keywords/cognitive-effects","display_name":"cognitive effects","score":0.6190000176429749},{"id":"https://openalex.org/keywords/clinical-trial-eligibility-criteria","display_name":"inclusion and exclusion criteria","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.8291056156158447},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7935878038406372},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7329632639884949},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5847526788711548},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5326105356216431},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2346220314502716}],"mesh":[{"descriptor_ui":"D000071066","descriptor_name":"Patient Reported Outcome Measures","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/jnci/djab015","doi":"https://doi.org/10.1093/jnci/djab015","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/djab015","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI: Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:33616650","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33616650","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8502480","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8502480/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Natl Cancer Inst","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8502480","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8502480/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Natl Cancer Inst","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1842042263","https://openalex.org/W1985794687","https://openalex.org/W2002330540","https://openalex.org/W2003591830","https://openalex.org/W2009781482","https://openalex.org/W2016146859","https://openalex.org/W2019177380","https://openalex.org/W2027348396","https://openalex.org/W2102335858","https://openalex.org/W2109330988","https://openalex.org/W2110236737","https://openalex.org/W2113464761","https://openalex.org/W2115499099","https://openalex.org/W2118638289","https://openalex.org/W2131076472","https://openalex.org/W2135001286","https://openalex.org/W2150906637","https://openalex.org/W2156635540","https://openalex.org/W2160182926","https://openalex.org/W2160834915","https://openalex.org/W2170424672","https://openalex.org/W2266520230","https://openalex.org/W2284281005","https://openalex.org/W2344792835","https://openalex.org/W2413118791","https://openalex.org/W2413971556","https://openalex.org/W2529940321","https://openalex.org/W2560367415","https://openalex.org/W2606041829","https://openalex.org/W2620925856","https://openalex.org/W2763750466","https://openalex.org/W2775052471","https://openalex.org/W2888995418","https://openalex.org/W2914157560","https://openalex.org/W2953285163","https://openalex.org/W2954875571","https://openalex.org/W2967092667","https://openalex.org/W2977506562","https://openalex.org/W2998727000","https://openalex.org/W4211181167","https://openalex.org/W4294214983"],"related_works":["https://openalex.org/W2977939617","https://openalex.org/W4293222009","https://openalex.org/W2597543786","https://openalex.org/W4405043927","https://openalex.org/W1600079158","https://openalex.org/W3031787110","https://openalex.org/W2413118791","https://openalex.org/W4221033594","https://openalex.org/W3171043130","https://openalex.org/W7223453658"],"abstract_inverted_index":{"BACKGROUND:":[0],"Clinician":[1],"reporting":[2,163,178,209],"of":[3,23,29,93,126,147,234,279],"symptomatic":[4,46,68,98,150,200,216,269],"adverse":[5],"events":[6],"(AEs)":[7],"in":[8,33,48,144,274],"phase":[9,49,275],"I":[10,50,54,276],"trials":[11],"uses":[12],"the":[13,24,30,63,258],"Common":[14],"Terminology":[15],"Criteria":[16],"for":[17,214,268],"Adverse":[18],"Events":[19],"(CTCAE).":[20],"The":[21],"utility":[22],"patient-reported":[25,149],"outcomes":[26],"(PROs)":[27],"version":[28],"CTCAE":[31,157,166],"(PRO-CTCAE)":[32,95],"this":[34],"setting":[35],"is":[36],"unknown.":[37],"This":[38],"prospective,":[39],"observational":[40],"study":[41],"compared":[42,101],"patient-":[43,94],"and":[44,75,80,85,106,135,155,190,241,249,281],"clinician-reported":[45,97],"AEs":[47,99,151,201,217,270],"patients.":[51],"METHODS:":[52],"Phase":[53],"study-eligible":[55],"patients":[56,116],"at":[57,70,103,247,255],"Princess":[58],"Margaret":[59],"were":[60,88,100,129,168],"surveyed":[61],"with":[62,131,159,202,229],"PRO-CTCAE":[64,137,154,176],"full-item":[65],"library":[66],"(78":[67],"AEs)":[69],"baseline":[71],"(BL),":[72],"mid-cycle":[73,76,109],"1,":[74],"2":[77],"(C2).":[78],"Patient":[79],"trial":[81],"characteristics,":[82],"best":[83],"response,":[84],"survival":[86],"data":[87],"collected.":[89],"Presence":[90],"or":[91,96,161,172,181,205],"absence":[92],"(kappa)":[102],"defined":[104],"timepoints":[105],"overall":[107,148],"(BL+":[108],"1":[110],"+":[111],"C2).":[112],"RESULTS:":[113],"Of":[114],"292":[115],"approached":[117],"from":[118,219],"May":[119],"2017":[120],"to":[121,194,224,264],"January":[122],"2019,":[123],"a":[124,203],"total":[125],"265":[127],"(90.8%)":[128],"consented,":[130],"243":[132],"(91.7%)":[133],"evaluable":[134],"552":[136],"surveys":[138],"(completion":[139],"rate":[140],"=":[141,222,227,239,245,253],"98.7%)":[142],"included":[143,185],"analyses.":[145],"Evaluation":[146],"identified":[152],"50":[153],"11":[156],"items":[158,167,177],"10%":[160,180],"greater":[162],"frequency.":[164],"Nineteen":[165],"reported":[169],"as":[170,179],"1%":[171],"less":[173],"despite":[174],"matched":[175],"greater.":[182],"Underreported":[183],"categories":[184,284],"sexual":[186],"health,":[187],"bodily":[188],"emissions,":[189],"cognition.":[191],"Clinician-":[192],"relative":[193],"patient-reporting":[195],"frequency":[196],"(ratio)":[197],"demonstrated":[198,257],"9":[199],"50-fold":[204],"more":[206],"lower":[207],"clinician":[208,235,272],"rate.":[210],"Overall":[211],"patient-clinician":[212,260,266],"agreement":[213,267],"individual":[215],"ranged":[218],"poor":[220],"(\u03ba":[221,226,238,244,252],"0.00-0.19)":[223],"moderate":[225,265],"0.40-0.59),":[228],"discordance":[230],"driven":[231],"by":[232],"lack":[233],"reporting.":[236],"Dyspnea":[237],"0.54)":[240],"peripheral":[242],"neuropathy":[243],"0.63)":[246],"BL":[248],"limb":[250],"edema":[251],"0.55)":[254],"C2":[256],"highest":[259],"agreement.":[261],"CONCLUSIONS:":[262],"Poor":[263],"suggests":[271],"underreporting":[273],"trials.":[277],"Analyses":[278],"severity":[280],"interference":[282],"PRO":[283],"are":[285],"ongoing.":[286]},"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2021-03-01T00:00:00"}